eli lilly glp-1 medications portfolio set to leapfrog Novo Nordisk in weight-loss drug race Eli Lilly Hits $1.01 Trillion

(18)F]FDG PET for mapping the cerebral glucose metabolic characteristics of drug-sensitive and drug-resistant epilepsy in pediatric patients

Global incidence, prevalence, and mortality of type 1 diabetes in 2021 with projection to 2040: s modelling study

The overindulgence in drinking (more than two standard drinks per day over a long period of time) may be associated with a significant elevation in the risk of an ironoverload in the tissue [27]

Inclusion of case-control studies, which are more susceptible to bias, may explain these discrepancies among meta-analyses (128)

The cost of a replacement is always less than the cost of running a protocol with degraded peptide